MDedge News, November 01, 2023 Dupilumab-Associated Lymphoid Reactions ... Medscape Medical News, October 30, 2023 ESMO 2023 Ocular MALT Lymphoma: Radiation Reduces Relapse While relapse is ...
Sanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal ... including relapsed/refractory classic Hodgkin’s lymphoma (cHL), cutaneous T-cell lymphoma and NK-cell ...